Delivery Order SPE2DR25D1053-SPE2DR26FV548
Award Date 1/14/26
Potential Completion Date 1/15/26
Potential Value $49K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,473.37 to AmerisourceBergen Drug Corp for the supply of Everolimus 5 mg tablets (30-count packages) on December 11, 2025, with a completion date of December 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,856.17 to AmerisourceBergen Drug Corp for the supply of Everolimus 1 mg tablets (60-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, representing a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order carries an ultimate completion date of August 12, 2025, with performance occurring at...
- The Defense Logistics Agency awarded a delivery order valued at $19,964.25 to AmerisourceBergen Drug Corp for the supply of Everolimus 1 mg tablets (60-count packaging) on January 9, 2026, with an ultimate completion date of January 12, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a delivery order valued at $39,614.76 to AmerisourceBergen Drug Corp for the supply of Everolimus 10 mg tablets (30-count units). This firm fixed price contract, awarded on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $45,979.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Everolimus 5 mg tablets (30-count units). The contract, with an ultimate completion date of December 22, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This award was not designated as a set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Everolimus 5 mg tablets in quantities of 30 units, with a ceiling value of $19,375.40. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set for ultimate completion on July 23, 2025, with performance being executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $6,374.93 to AmerisourceBergen Drug Corp for Everolimus 10 mg tablets (30-count units) on December 8, 2025, with completion expected by December 9, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. Everolimus is an immunosuppressant and anticancer medication used in various medical applications,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Everolimus 10 mg tablets (30-count) valued at $19,124.79 under a firm fixed-price contract type. The delivery order was competitively awarded without set-aside provisions and carries an ultimate completion date of October 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award represents a continuation of the...
- The Defense Logistics Agency awarded a $3,977.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Everolimus 0.75 mg, with a completion deadline of September 30, 2025. This non-set-aside contract was competitively awarded and performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $6,039.26 to AmerisourceBergen Drug Corp for the supply of Everolimus 5 mg tablets (30-count packaging) on November 24, 2025, with completion scheduled for November 25, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Everolimus is a pharmaceutical product used in immunosuppression and cancer...